MUMBAI (Reuters) - U.S. private equity funds Bain Capital LLC and Carlyle Group LP are in separate talks to buy up to a 75 percent stake in Famy Care Ltd for about $400-$450 million, two sources with direct knowledge of the matter told Reuters.
Another private equity fund, Warburg Pincus, is also holding separate discussions to buy a controlling stake in the Mumbai-based drug maker of contraceptive pills for women, the sources said.
Hong Kong based AIF Capital will sell its 10-15 percent stake along with Famy promoters, said the sources, who declined to be named as the transaction is not yet public.
The sources did not specify which specific promoters were selling their stakes.
"An official auction process is on. Final bids are expected by month-end," said one of the sources.
Bain, Carlyle and Warburg Pincus declined to comment, while Famy Care and AIF Capital did not respond to emails or calls seeking comment.
Unlisted Famy Care produces contraceptive pills, injectables and devices, according to its web site.
(Reporting by Indulal PM; Editing by Rafael Nam)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app